The quarterly release of Eclipse IDE 2026-03 brings some new features alongside bug fixes, such as the Java refactoring function "Convert Class to Record".

Keeping up with the world of Java programming can feel like a full-time job itself. New versions drop regularly, tools change, and what was best practice last year might be a bit… dated now. This ...

Media Eclipse Award winners will be presented trophies at the 55th Annual Resolute Racing Eclipse Awards ceremony and dinner at The Breakers Palm Beach in Florida Jan. 22. Dickstein, of Malta, N.Y., ...

Java ranked third in the Tiobe Index for January 2026 at 8.71%, holding steady behind Python and C and just ahead of C++. Tiobe named C# its Programming Language of the Year for 2025 after the largest ...

Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that the Company has granted Norgine Pharma UK Limited, an affiliate of Norgine, a leading European specialty pharmaceutical company, an exclusive ...

Before installing JDK, it’s imperative to check whether your computer is compatible with the JDK version. JDK is compatible with Windows 11/10/8/7, but you need to be running the 64-bit version of the ...

I believe that a good speculative biotech to go over for the "Exclusive BAC Subscribers Article" would be Vir Biotechnology (VIR). The reason why I want to go over this biotech next is because it is ...

The Eclipse Foundation has released the latest version of its enterprise Java application platform in Jakarta EE 11, promising simpler data access, streamlined testing processes, and Java 21 support.

Jakarta EE, a working group hosted by the Eclipse Foundation, today announced the general availability of the Jakarta EE 11 Platform, the latest version of its enterprise Java platform. The new ...

(RTTNews) - Northrop Grumman Corp. (NOC), Thursday announced that it has committed $50 million to Firefly Aerospace to accelerate production of their jointly developed medium class launch vehicle, ...

CEO Marianne De Backer emphasized Vir's progress in advancing its infectious disease and oncology programs. Key milestones include initiating the ECLIPSE Phase III registrational program for hepatitis ...